Nelson, Van Denburg & Campbell Wealth Management Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

  • $2.42 Billion
  • Q3 2024

A detailed history of Nelson, Van Denburg & Campbell Wealth Management Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Nelson, Van Denburg & Campbell Wealth Management Group, LLC holds 922 shares of REGN stock, worth $656,832. This represents 0.04% of its overall portfolio holdings.

Number of Shares
922
Previous 921 0.11%
Holding current value
$656,832
Previous $967,000 0.21%
% of portfolio
0.04%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$1024.09 - $1201.76 $1,024 - $1,201
1 Added 0.11%
922 $969,000
Q2 2024

Aug 13, 2024
SELL
$883.2 - $1071.19 $57,408 - $69,627
-65 Reduced 6.59%
921 $967,000
Q1 2024

Apr 30, 2024
SELL
$902.69 - $993.35 $37,912 - $41,720
-42 Reduced 4.09%
986 $949,000
Q3 2023

Oct 17, 2023
BUY
$692.45 - $844.37 $2,769 - $3,377
4 Added 0.39%
1,028 $846,000
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $153,178 - $166,306
-217 Reduced 17.49%
1,024 $738,000
Q2 2022

Aug 10, 2022
SELL
$548.35 - $738.84 $205,631 - $277,065
-375 Reduced 23.21%
1,241 $732,000
Q1 2022

May 13, 2022
SELL
$595.12 - $698.43 $179,726 - $210,925
-302 Reduced 15.75%
1,616 $1.13 Million
Q2 2021

Jul 27, 2021
SELL
$472.8 - $558.54 $117,727 - $139,076
-249 Reduced 11.49%
1,918 $1.07 Million
Q1 2021

May 11, 2021
SELL
$446.73 - $548.2 $19,656 - $24,120
-44 Reduced 1.99%
2,167 $1.03 Million
Q4 2020

Feb 09, 2021
SELL
$478.3 - $607.98 $48,786 - $62,013
-102 Reduced 4.41%
2,211 $1.07 Million
Q3 2020

Oct 20, 2020
BUY
$544.75 - $658.21 $140,000 - $169,159
257 Added 12.5%
2,313 $1.29 Million
Q2 2020

Jul 02, 2020
SELL
$493.32 - $643.92 $45,878 - $59,884
-93 Reduced 4.33%
2,056 $1.28 Million
Q1 2020

Apr 01, 2020
BUY
$336.18 - $494.43 $9,749 - $14,338
29 Added 1.37%
2,149 $1.05 Million
Q3 2019

Oct 09, 2019
BUY
$273.46 - $318.39 $36,096 - $42,027
132 Added 6.64%
2,120 $588,000
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $21,571 - $29,867
72 Added 3.76%
1,988 $622,000
Q2 2018

Aug 16, 2018
BUY
$284.6 - $344.99 $57,489 - $69,687
202 Added 11.79%
1,916 $661,000
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $37,582 - $46,859
119 Added 7.46%
1,714 $590,000
Q4 2017

Feb 08, 2018
BUY
$358.63 - $469.95 $563,049 - $737,821
1,570 Added 6280.0%
1,595 $600,000
Q2 2017

Aug 15, 2017
BUY
N/A
25
25 $12,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Nelson, Van Denburg & Campbell Wealth Management Group, LLC Portfolio

Follow Nelson, Van Denburg & Campbell Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email